Changes of Ocular Structures After Hemodialysis in Patients With Chronic Kidney Diseases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

40 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-09-09

Study Completion Date

2017-12-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate the effect of hemodialysis on various ophthalmologic parameters in patients with end-stage kidney disease (ESRD).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prevalence of Fatigue in Hemodialysis Patients

NCT01846754

Hemodialysis Patients

COMPLETED

Evaluation of Ocular Surface in Hemodialysis Patients by Ocular Surface Analyzer

NCT04949295

Hemodialysis Ocular Surface Disease Dry Eye +1 more

COMPLETED

Relationship Between Hemodynamic Change and Fluid Removed During Hemodialysis

NCT03901794

Hemodialysis Complication Hemodialysis-Induced Symptom

COMPLETED

Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients

NCT00739843

Dementia Cognition End-stage Renal Disease

TERMINATED

Influencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis Patients

NCT04433455

Hemodialysis Cognitive Impairment Cerebrovascular Disorders

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Subjects: patients with ESRD undergoing hemodialysis at the Dialysis Center of Hanyang Guri Hospital

Ocular parameters: visual acuity, intraocular pressure, axial length, OCT Other systemic parameters: body weight, ultrafiltration volume, and systolic/diastolic blood pressure

All measurements were performed near the dialysis center. Measurements were performed on Monday (for patients who underwent dialysis sessions on Monday, Wednesday, and Friday) or Tuesday (for patients who underwent dialysis sessions on Tuesday, Thursday, and Saturday.

All parameters were measured before and after the hemodialysis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Kidney Diseases Hemolysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

patients with chronic kidney diseases

patients with end stage retinal disease undergoing hemodialysis underwent various ophthalmologic exams before and after hemodialysis.

ophthalmologic exams

Intervention Type OTHER

ophthalmologic exams such as vision, intraocular pressure, axial length and optical coherence tomography

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

ophthalmologic exams

ophthalmologic exams such as vision, intraocular pressure, axial length and optical coherence tomography

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 1\) patients who are regularly dialyzed in our dialysis room to participate in the study
* 2\) patients who agree with our study protocol
* 3\) patients who have unstable general condition

Exclusion Criteria

* 1\) previous intraocular surgery, (2) baseline IOP greater than 22 mmHg, (3) presence of glaucomatous optic disc changes including excavation, thinning, or notching of the neuroretinal rim, (4) axial length greater than 26 mm, and (5) combined macular and retinal diseases such as central serous chorioretinopathy and age-related macular degeneration, except diabetic retinopathy.

Minimum Eligible Age

20 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No